Delivery Order SPE2DR25D3301-SPE2DR26F20LB
- Not listed
- This delivery order award to AmerisourceBergen Drug Corp, valued at $1,211.60, covers the supply of Ultane 250 ml in pen bottle format. The contract was competitively awarded without set-aside designations on December 16, 2025, with an ultimate completion date of December 17, 2025. The Defense Logistics Agency funds this firm fixed-price delivery order, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ultane Liquid 250ML, an anesthetic agent commonly used in surgical and medical procedures. This firm fixed-price delivery order, valued at $1,409.54, is scheduled for completion by December 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ultane 250 mL pen bottles with a ceiling value of $1,155.12. This firm fixed price delivery order, which must be completed by August 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract action performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,012.42 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format, with delivery to be completed by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for Ultane Liquid 250ML with a ceiling value of $3,202.32. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on May 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- This delivery order, valued at $2,900.42, was awarded on September 2, 2025, to AmerisourceBergen Drug Corp for the supply of Ultane liquid 250ML. The contract is a firm fixed price award with no set-aside designation, executed through competitive procurement. The award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 3, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20LBDelivery Order
This delivery order, valued at $3,625.18, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for 250 milliliters of Ultane in pen bottle format. The award was issued on January 8, 2026, with an ultimate completion date of January 9, 2026, and represents a non-set-aside competitive procurement. The place of performance is Conshohocken, Pennsylvania, where the prime contractor maintains its corporate headquarters. This delivery order is executed under Amerisourcebergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and running through December 2026. The Defense Logistics Agency, as the funding federal agency, procures Ultane through this established vehicle to support military healthcare requirements. Ultane (sevoflurane) is a volatile anesthetic commonly used in surgical and medical procedures within military treatment facilities and veterans' healthcare systems. By leveraging the large umbrella IDC, the Defense Logistics Agency can efficiently fulfill specific pharmaceutical needs through firm fixed-price delivery orders, ensuring reliable supply chain management for essential anesthetic medications required across the Department of Defense medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 1/7/26 |